Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Pancreatic Cancer (Jul 2025)
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Spastic paraplegia proteins spastizin and spatacsin mediate autophagic lysosome reformation
Jaerak Chang, … , Seongju Lee, Craig Blackstone
Jaerak Chang, … , Seongju Lee, Craig Blackstone
Published November 3, 2014
Citation Information: J Clin Invest. 2014;124(12):5249-5262. https://doi.org/10.1172/JCI77598.
View: Text | PDF
Research Article Neuroscience

Spastic paraplegia proteins spastizin and spatacsin mediate autophagic lysosome reformation

  • Text
  • PDF
Abstract

Autophagy allows cells to adapt to changes in their environment by coordinating the degradation and recycling of cellular components and organelles to maintain homeostasis. Lysosomes are organelles critical for terminating autophagy via their fusion with mature autophagosomes to generate autolysosomes that degrade autophagic materials; therefore, maintenance of the lysosomal population is essential for autophagy-dependent cellular clearance. Here, we have demonstrated that the two most common autosomal recessive hereditary spastic paraplegia gene products, the SPG15 protein spastizin and the SPG11 protein spatacsin, are pivotal for autophagic lysosome reformation (ALR), a pathway that generates new lysosomes. Lysosomal targeting of spastizin required an intact FYVE domain, which binds phosphatidylinositol 3-phosphate. Loss of spastizin or spatacsin resulted in depletion of free lysosomes, which are competent to fuse with autophagosomes, and an accumulation of autolysosomes, reflecting a failure in ALR. Moreover, spastizin and spatacsin were essential components for the initiation of lysosomal tubulation. Together, these results link dysfunction of the autophagy/lysosomal biogenesis machinery to neurodegeneration.

Authors

Jaerak Chang, Seongju Lee, Craig Blackstone

×

Figure 2

Depletion of spastizin or spatacsin causes prominent LPO enlargement.

Options: View larger image (or click on image) Download as PowerPoint
Depletion of spastizin or spatacsin causes prominent LPO enlargement.
(A...
(A) HeLa (left) or hTERT RPE-1 (right) cells transfected with control (siCTL), spastizin (siSPG15), or spatacsin (siSPG11) siRNAs were immunostained for LAMP1. Nuclei were stained with Hoechst 33342 (blue). Boxes within images in the left columns are enlarged (original magnification, ×4) in the right columns. (B and C) Numbers of (B) HeLa or (C) hTERT RPE-1 cells from A with >20 enlarged LPOs (LPOs with > 0.5 μm diameter) were quantified (n = 3; >200 cells per experiment). (D) HeLa cells were transfected with siCTL, siSPG15, or siSPG11 siRNAs, and cell lysates were immunoblotted. Molecular weight standards (in kDa) are at the left. (E) LAMP1 protein levels from D were normalized to β-tubulin (n = 3). (F) HeLa cells were transfected with siCTL or siSPG15 siRNAs and subsequently with the indicated HA-spastizin constructs or an empty vector and then immunostained for LAMP1 (green) and HA-epitope (red). Merged images are shown in the bottom row. (G) Cells with >20 enlarged LPOs from F were quantified (n = 3; >100 cells per experiment). Scale bar: 10 μm. Mean ± SD are shown. One-way ANOVA followed by Tukey’s multiple comparison test, ***P < 0.001.

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts